SG
Stonnington Group’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $507K | Sell |
12,019
-2,000
| -14% | -$84.4K | 0.13% | 147 |
|
2022
Q4 | $524K | Sell |
14,019
-15,500
| -53% | -$579K | 0.14% | 124 |
|
2022
Q3 | $1.57M | Buy |
29,519
+6,422
| +28% | +$341K | 0.44% | 64 |
|
2022
Q2 | $1.34M | Sell |
23,097
-23,500
| -50% | -$1.36M | 0.36% | 67 |
|
2022
Q1 | $3.41M | Buy |
46,597
+1,050
| +2% | +$76.9K | 0.82% | 35 |
|
2021
Q4 | $2.83M | Buy |
45,547
+24,100
| +112% | +$1.5M | 0.61% | 50 |
|
2021
Q3 | $1.03M | Sell |
21,447
-4,100
| -16% | -$197K | 0.23% | 107 |
|
2021
Q2 | $1.44M | Buy |
25,547
+500
| +2% | +$28.2K | 0.32% | 87 |
|
2021
Q1 | $1.55M | Buy |
+25,047
| New | +$1.55M | 0.38% | 76 |
|